LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 29th, 2022 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances)
REVISED CONSULTING AGREEMENT – EFFECTIVE October 1, 2021Consulting Agreement • March 29th, 2022 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS CONSULTING AGREEMENT, effective October 1, 2021 and dated as of this October 19, 2021 (this "Agreement"), is by and between Susan Stewart located at 62 Larchwood Drive, Cambridge MA 02138 ("Consultant"), and Candel Therapeutics, Inc. with principal executive offices at 117 Kendrick Street, Needham, MA 02494 ("Company").
EMPLOYMENT AGREEEMENTEmployment Agreement • March 29th, 2022 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made between Candel Therapeutics, Inc., a Delaware corporation (the “Company”), and Francesca Barone, M.D., Ph.D. (the “Executive”) and is made effective as of February 3, 2022 (the “Effective Date”).
